Skip to main content

The Wistar Institute

|

Wistar Institute Researchers Discover New Combination Therapy Approach for Metastatic Ovarian Cancer

PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular and Cellular Oncogenesis Program, and lab have discovered a new approach to treating ovarian c…
|

Wistar Trainee Research Symposium

Special Event Friday, Feb. 28, 2025 8:00 a.m. to 6:00 p.m. The Wistar Institute Trainee Research Symposium is an annual all-day event showcasing academic research excellence and diversity in the Philadelphia area. Trainees who are interested in pres…
|

Collaboration between The Wistar Institute and Cameroon Researchers Reveals HIV Latency Reversing Properties in African Plant

PHILADELPHIA — (November 19, 2024) — A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of Afr…
|

The Wistar Institute’s Education & Training Center Receives $100,000 NIIMBL eXperience Grant

PHILADELPHIA — (NOV. 14, 2024) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute. The program…
|

Chronic Disease and Corgis: The Varied Interests of Wistar’s Dr. Samantha Soldan

Infectious disease specialist & senior scientist in Wistar’s Lieberman lab, Dr. Soldan studies the connection between M.S. and Epstein Barr Virus. She is most intrigued with how the body responds to disease—why sleeping viruses reactivate, how a…
|

Mono, Multiple Sclerosis, and Cells That Live Forever: Wistar’s Dr. Paul Lieberman on Progress in EBV Research

Paul M. Lieberman, Ph.D., is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He studies how certain viruses, such as Epstein-Barr virus, establish a long-term latent infection that can lead to…
|

Wistar Institute President & CEO Dr. Dario Altieri Appointed to the Board of Directors of the Chamber of Commerce for Greater Philadelphia

PHILADELPHIA — (October 22, 2024) —President and CEO of The Wistar Institute Dario Altieri, M.D., has been appointed to the Board of Directors of the Chamber of Commerce for Greater Philadelphia. The appointment marks a continuation of Altieri’s ser…
|

Maureen Murphy, Ph.D., of The Wistar Institute Named 2024 Woman of Influence

PHILADELPHIA — (October 11, 2024) — In the latest issue of The Philadelphia Business Journal, The Wistar Institute’s Maureen Murphy, Ph.D. — Deputy Director of the Ellen and Ronald Caplan Cancer Center and Ira Brind Professor & Program Leader of the…
|

2024 Trot for Trainees

Special Event Sunday, Nov. 17, 2024 10:00 a.m. to 12:00 p.m. Support the Wistar Trainee Association and their transformative research by joining us at the 2024 Trot for Trainees. This 2-mile fun run and walk starts at the Wistar facility at 3601 Spr…
|

The Wistar Institute Celebrates Bold Science // Global Impact Campaign Success

The Wistar Institute celebrated the most successful fundraising campaign in its history with an evening reception at the Philadelphia Museum of Art. Donors, board members and Wistar staff gathered in the soaring, Frank Gehry designed Williams Forum…
close carousel